Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF (Q65364104)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF |
clinical trial |
Statements
RELAX-AHF-2 (English)
0 references
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients (English)
0 references
2 October 2013
0 references
23 January 2017
0 references
6,600
0 references
18 year
0 references